Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies.
MAbs
; 6(5): 1300-13, 2014.
Article
em En
| MEDLINE
| ID: mdl-25517315
Palavras-chave
ADCC, antibody-dependent cell-mediated cytotoxicity; BCR, B-cell receptor; CD20; CDC, complement-dependent cytotoxicity; CFSE, carboxyfluorescein succinimidyl ester; CLL, chronic lymphocytic leukemia; DLBCL, diffuse large B-cell lymphoma; NHL, non-Hodgkin lymphoma; PBMC, peripheral blood mononuclear cells; SFKs, SRC family kinases; SRC family kinases; dasatinib; ofatumumab; rituximab
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Quinases da Família src
/
Antígenos CD20
/
Inibidores de Proteínas Quinases
/
Anticorpos Monoclonais
/
Neoplasias
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article